This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
O’Dwyer PJ, Leyland-Jones B, Alonso MT, Marsoni S, Wittes RE . Etoposide (VP-16-213): current status of an active anticancer drug. N Engl J Med 1985; 312: 692–700.
O’Reily SE, Klimo P, Connors JM . The evolving role of etoposide in the management of lymphoma and Hodgkin’s disease. Cancer 1991; 67: 271–280.
Weiss RB. In: Perry MC (ed). The Chemotherapy Source Book, 2nd edn. Lippincott Williams and Wilkins: Baltimore, MD, USA, 1996, pp 613-634.
Chen YB, Lane AA, Logan BR, Zhu X, Akpet G, Aljurt MD et al. Impact of conditioning regiment on outcomes for patient with lymphoma undergoing high-dose therapy with autologous hematopoietic cell transplantation. Biol Blood Marrow Transplant 2015; 21: 1046–1053.
Perales MA, Ceberio I, Armand P, Burns LJ, Chen R, Cole PD et al. Role of cytotoxic therapy with hematopoietic cell transplantation in the treatment of Hodgkin lymphoma: guidelines from the American Society for Blood and Marrow Transplantation. Biol Blood Marrow Transplant 2015; 21: 971–983.
Siderov J, Prasad P, del Boer R, Desai J . Safe administration of etoposide phosphate after hypersensitivity reaction to intravenous etoposide. Br J Cancer 2002; 86: 12–13.
Kasperek C, Black CD . Two case of suspected immunological-based hypersensitivity reaction to etoposide therapy. Ann Pharmacother 1992; 26: 1227–1230.
Schacter L . Etoposide phosphate: what, why, where and how? Semin Oncol 1996; 23 (Suppl 13):1–7.
Biljana L, Vera M, Marina D, Sanja M, Katerina J, Zlatko H . Hypersensitivity to etoposide in case of metastatic choriocarcinoma. Case Rep Oncol 2013; 6: 490–492.
Castells M . Desensitization for drug allergy. Curr Opin Allergy Clin Immunol 2006; 6: 476–481.
Mariana C, del Carmen Sancho-Serra M, Maria S . Hypersensitivity to antineoplastic agents: mechanisms and treatment with rapid desensitization. Cancer Immunol Immunother 2012; 61: 1575–1584.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Polistena, P., Tran, Q., Cirillo, M. et al. Etoposide phosphate hypersensitivity overcome using a desensitisation programme enabling optimal therapy for relapsed Hodgkin lymphoma. Bone Marrow Transplant 52, 455–456 (2017). https://doi.org/10.1038/bmt.2016.288
Published:
Issue Date:
DOI: https://doi.org/10.1038/bmt.2016.288
This article is cited by
-
Etoposide phosphate
Reactions Weekly (2017)